RetourAIDS
acquired immunodeficiency syndrome
BCG
bacille Calmette-Guérin
CFP-10
culture filtrate protein 10
CI
confidence interval
DCE
discrete choice experiment
DOI
declaration of interest
DST
drug susceptibility testing
ELISA
enzyme-linked immunosorbent assay
ELISPOT
enzyme-linked immunospot
ERG
External Review Group
ESAT-6
early secretory antigenic target 6 kDa protein
GDG
Guideline Development Group
GRADE
Grading of Recommendations Assessment, Development and Evaluation
HIV
human immunodeficiency virus
IFN-γ
interferon-gamma
IGRA
interferon-gamma release assay
ISR
injection site reaction
LMIC
low- and middle-income countries
Mtb
Mycobacterium tuberculosis
NTM
nontuberculous mycobacteria
NTP
national tuberculosis programme
PICO
population, intervention, comparator and outcome
People with HIV
people living with HIV
PPD
purified protein derivative
PPD-S
purified protein derivative–standard
QALY
quality-adjusted life year
QFT-G
QIAGEN QuantiFERON®-TB Gold
QFT-GIT
QIAGEN QuantiFERON-TB Gold In-Tube
RR
risk ratio
TB
tuberculosis
TBST
Mycobacterium tuberculosis antigen-based skin test
TPT
TB preventive treatment
T-Spot
Oxford Immunotec T-SPOT®.TB
TST
tuberculin skin test
United Kingdom
United Kingdom of Great Britain and Northern Ireland
USA
United States of America
WHO
World Health Organization
WHO/GTB
World Health Organization Global TB Programme